The underlying mechanisms suggest that while PDE8B expression is reduced in high-grade gliomas, it actively promotes tumor proliferation, invasion, and growth in high-grade glioblastoma cell lines, possibly due to differing cell origins in high-grade versus low-grade gliomas. Here, PDE8B is linked to central nervous system cancer.